PAMELA LAUGHLIN: Open Payments
NPI 1336443670 · RUSHVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$218 in 9 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $218
Food & beverage: $218
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $49 |
| AVYXA PHARMA, LLC | 1 | $28 |
| Pharmacosmos Therapeutics Inc. | 1 | $27 |
| Geron Corporation | 1 | $25 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| PUMA BIOTECHNOLOGY, INC. | 1 | $24 |
| Genentech USA, Inc. | 1 | $21 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $20 |
Products named: KYXATA, MONOFERRIC, RYTELO, CALQUENCE, KISQALI, NERLYNX, Phesgo, ENJAYMO.
Industry payments across IN — which companies pay providers there.
